What is the address of Dr. Sandhya Fonseca, Anatomo-Pathologie?

The registered office of Dr. Sandhya Fonseca, Anatomo-Pathologie is located at Rue du Progrès 2 box 2, 1400 Nivelles.

Is Dr. Sandhya Fonseca, Anatomo-Pathologie still active?

Yes. According to the CBE (25 September 2026) Dr. Sandhya Fonseca, Anatomo-Pathologie is active, legal situation “Normale toestand”, started on 26 October 2017.

Is Dr. Sandhya Fonseca, Anatomo-Pathologie registered on Peppol?

Yes, Dr. Sandhya Fonseca, Anatomo-Pathologie is registered on the Peppol network with ID 0208:0683765074.

What is the enterprise number of Dr. Sandhya Fonseca, Anatomo-Pathologie?

The enterprise number of Dr. Sandhya Fonseca, Anatomo-Pathologie is BE0683765074.

When was Dr. Sandhya Fonseca, Anatomo-Pathologie founded?

Dr. Sandhya Fonseca, Anatomo-Pathologie was founded on 26 October 2017.

Who are the directors of Dr. Sandhya Fonseca, Anatomo-Pathologie?

According to the 2025 annual accounts, the directors of Dr. Sandhya Fonseca, Anatomo-Pathologie are: Sandhya FONSECA.

Is Dr. Sandhya Fonseca, Anatomo-Pathologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 October 2017; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sandhya Fonseca, Anatomo-Pathologie make in 2025?

Dr. Sandhya Fonseca, Anatomo-Pathologie posted a profit after taxes of € 92,439 in financial year 2025.

What is the revenue of Dr. Sandhya Fonseca, Anatomo-Pathologie?

As a small company, Dr. Sandhya Fonseca, Anatomo-Pathologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 172,102.

Dr. Sandhya Fonseca, Anatomo-Pathologie (Private Limited)

Dossier Dr. Sandhya Fonseca, Anatomo-Pathologie, printed on 25 September 2026 from databakkes.be/en/0683765074/dr-sandhya-fonseca-anatomo-pathologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sandhya Fonseca, Anatomo-Pathologie from Nivelles, company number BE0683765074, closed financial year 2025 with a result of € 92,439 after tax. For that financial year Dr. Sandhya Fonseca, Anatomo-Pathologie recorded a gross margin of € 172,102 and equity of € 371,807. Compared with financial year 2024, the result moved from € 102,713 to € 92,439. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 3, 2026.

What it is worth Healthy

€ 371,807

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 92,439

▼ 10% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 120,833 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 14,003

▼ 14% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 131,633

▲ 2% vs 2024

€ 52,929 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 123,898

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,814

▼ 48% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 167,555 Gross margin 2022: € 167,555 First fiscal year in the series	€ 165,740 Gross margin 2023: € 165,740 ▼ 1% vs 2022 (€ 167,555) Unfavourable step	€ 196,834 Gross margin 2024: € 196,834 ▲ 19% vs 2023 (€ 165,740) Favourable step	€ 172,102 Gross margin 2025: € 172,102 ▼ 13% vs 2024 (€ 196,834) Unfavourable step	▼ 13%
Profit after taxes	€ 83,059 Profit after taxes 2022: € 83,059 First fiscal year in the series	€ 83,628 Profit after taxes 2023: € 83,628 ▲ 1% vs 2022 (€ 83,059) Favourable step	€ 102,713 Profit after taxes 2024: € 102,713 ▲ 23% vs 2023 (€ 83,628) Favourable step	€ 92,439 Profit after taxes 2025: € 92,439 ▼ 10% vs 2024 (€ 102,713) Unfavourable step	▼ 10%
Equity	€ 247,460 Equity 2022: € 247,460 First fiscal year in the series	€ 298,288 Equity 2023: € 298,288 ▲ 21% vs 2022 (€ 247,460) Favourable step	€ 400,201 Equity 2024: € 400,201 ▲ 34% vs 2023 (€ 298,288) Favourable step	€ 371,807 Equity 2025: € 371,807 ▼ 7% vs 2024 (€ 400,201) Unfavourable step	▼ 7%
Total debts	€ 290,035 Total debts 2022: € 290,035 First fiscal year in the series	€ 313,088 Total debts 2023: € 313,088 ▲ 8% vs 2022 (€ 290,035) Unfavourable step	€ 292,125 Total debts 2024: € 292,125 ▼ 7% vs 2023 (€ 313,088) Favourable step	€ 381,129 Total debts 2025: € 381,129 ▲ 30% vs 2024 (€ 292,125) Unfavourable step	▲ 30%
Cash	€ 26,308 Cash 2022: € 26,308 First fiscal year in the series	€ 38,012 Cash 2023: € 38,012 ▲ 44% vs 2022 (€ 26,308) Favourable step	€ 36,951 Cash 2024: € 36,951 ▼ 3% vs 2023 (€ 38,012) Unfavourable step	-
Land & buildings	€ 274,034 Land & buildings 2022: € 274,034 First fiscal year in the series	€ 270,722 Land & buildings 2023: € 270,722 ▼ 1% vs 2022 (€ 274,034) Unchanged	€ 248,069 Land & buildings 2024: € 248,069 ▼ 8% vs 2023 (€ 270,722) Unchanged	€ 227,229 Land & buildings 2025: € 227,229 ▼ 8% vs 2024 (€ 248,069) Unchanged	▼ 8%
Retained profit	€ 235,060 Retained profit 2022: € 235,060 First fiscal year in the series	€ 285,888 Retained profit 2023: € 285,888 ▲ 22% vs 2022 (€ 235,060) Favourable step	€ 387,801 Retained profit 2024: € 387,801 ▲ 36% vs 2023 (€ 285,888) Favourable step	€ 359,407 Retained profit 2025: € 359,407 ▼ 7% vs 2024 (€ 387,801) Unfavourable step	▼ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 32,800 Dividend 2023: € 32,800 Unchanged (€ 0) Unchanged	€ 800 Dividend 2024: € 800 ▼ 98% vs 2023 (€ 32,800) Unchanged	€ 120,833 Dividend 2025: € 120,833 ▲ € 120,033 vs 2024 (€ 800) Unchanged	▲ € 120,033
Bank debt	€ 182,001 Bank debt 2022: € 182,001 First fiscal year in the series	€ 154,429 Bank debt 2023: € 154,429 ▼ 15% vs 2022 (€ 182,001) Favourable step	€ 129,039 Bank debt 2024: € 129,039 ▼ 16% vs 2023 (€ 154,429) Favourable step	€ 131,633 Bank debt 2025: € 131,633 ▲ 2% vs 2024 (€ 129,039) Unfavourable step	▲ 2%
Balance sheet total	€ 537,494 Balance sheet total 2022: € 537,494 First fiscal year in the series	€ 611,375 Balance sheet total 2023: € 611,375 ▲ 14% vs 2022 (€ 537,494) Unchanged	€ 692,327 Balance sheet total 2024: € 692,327 ▲ 13% vs 2023 (€ 611,375) Unchanged	€ 752,937 Balance sheet total 2025: € 752,937 ▲ 9% vs 2024 (€ 692,327) Unchanged	▲ 9%

Key figures of Dr. Sandhya Fonseca, Anatomo-Pathologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dr. Sandhya Fonseca, Anatomo-Pathologie?

What happened at Dr. Sandhya Fonseca, Anatomo-Pathologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 3, 2026 New annual accounts for financial year 2025: profit of € 92,439 (▼ 10% vs 2024). filed late Source: NBB ↗
Oct 26, 2017 New establishment in Nivelles. KBO
Oct 26, 2017 Start of the company according to the CBE. KBO

In short

From € 83,059 profit in 2022 to € 92,439 profit in 2025.

Paid € 148,421 in corporate taxes since 2022.

Best year ever: 2024, with € 102,713 profit.

Paid out € 154,433 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sandhya Fonseca, Anatomo-Pathologie? We notify you, reason included.

Follow Dr. Sandhya Fonseca, Anatomo-Pathologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sandhya FONSECA

Dr. Sandhya Fonseca, Anatomo-Pathologie

Behind Dr. Sandhya Fonseca, Anatomo-Pathologie is Sandhya FONSECA.

See the full network in the app

Directors

According to the 2025 annual accounts

Sandhya FONSECA

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Progrès 2 box 2

1400 Nivelles

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

OPUS MARBLE BELGIUM

€ 1.3 million gross margin · 2025

4S SERVICES

€ -2,613 gross margin · 2025

BD&TF

€ 38,975 gross margin · 2025

ATLASIA

€ 21,163 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0683.765.074
VAT number: BE 0683.765.074
Registered office: Rue du Progrès 2 bus 2, 1400 Nivelles
Names & denominations: Dr. Sandhya Fonseca, Anatomo-Pathologie · SANPATH
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 October 2017
Peppol: Active · Active since 18 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗